Chagasic Cardiopathy

Author:

COSSIO PATRICIO M.1,DIEZ CARLOS1,SZARFMAN ANA1,KREUTZER EDUARDO1,CANDIOLO BARTOLOMÉ1,ARANA ROBERTO M.1

Affiliation:

1. From the Laboratory of Rheumatology and Immunology and the Cardiology Units, Centro de Educacion Medica e Investigaciones Clinicas (CEMIC), Buenos Aires, and Hospital Ingenio Ledesma, Provincia de Jujuy; the Department of Microbiology and Parasitology and Comision para el Estudio Integral de la Enfermedad de Chagas, Facultad de Medicina, Universidad de Buenos Aires; and the Escuela Municipal de Cirugia Cardiovascular, Hospital Durand, Buenos Aires, Argentina.

Abstract

Twenty-four out of 25 patients with Chagas' heart disease have circulating immunoglobulins which react by indirect immunofluorescence technique with endocardium, interstitium and blood vessels of the heart. With skeletal muscle the reaction was observed in interstitium and vascular structures, but with other organs it was limited to vascular structures. This endocardial-vascular-interstitial factor (EVI) fixed complement. Some evidence indicated that this reaction could be obtained using the serum and tissues from the same patient: for instance, in one positive case a right atrium biopsy was performed. When this substrate was used for indirect immunofluorescence, employing the patient's own serum, positive results were obtained. Specificity is not related to AB blood group systems, or to Forssman or Wassermann antigens. The reacting factor was effectively absorbed from sera with organ homogenates, and with guinea pig red blood cells although it was independent of heterophil antibodies. In almost all cases studied, the EVI factor of the serum, when absorbed with epimastigotes of T. cruzi , results in a negative reaction, suggesting that the genesis of the reacting gamma globulin is related to antigens of T. cruzi. The EVI factor was also observed in 19 of 47 asymptomatic controls from an endemic area with positive serology for T. cruzi and in 3 of 27 with negative serology. These 3 cases had anti- T. cruzi antibodies in titers just below those considered of clinical value. The EVI factor was not observed in 119 normal individuals and 286 patients with selected cardiovascular diseases or another pathology from a nonendemic area. These findings and those mentioned above were statistically significant ( P < 0.001). These results indicate the possibility of a more accurate diagnosis of chagasic myocardiopathy based on the study of the EVI factor, because in an individual case the diagnosis of chronic chagasic cardiopathy can be considered with a low probability in the absence of this factor.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Clinical and epidemiological study of chronic heart involvement in Chagas' disease;Bull WHO,1956

2. Chagas' disease. Report of a study group;WHO. Techn Rep Ser,1960

3. Histopathology in Rockland Mice Immunized against American Trypanosomiasis (Chagas' Disease) *

4. Miocardite chag'asica (Estudio morfologico de 38 casos comprovados pelo encontro de parasito nas secioes histologicas);Gaz Med Bahia,1966

Cited by 189 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Chagas disease, malaria, and less common protozoan and helminth infections;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. The Role of Autoantibodies in Companion Animal Cardiac Disease;Veterinary Clinics of North America: Small Animal Practice;2023-11

3. Cardioimmunology: An Interdisciplinary Approach;Interdisciplinary Biotechnological Advances;2023

4. Modulation of Host Cell Apoptosis byTrypanosoma cruzi: Repercussions in the Development of Chronic Chagasic Cardiomyopathy;Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention;2022-07-13

5. Echocardiographic parameters, speckle tracking, and brain natriuretic peptide levels as indicators of progression of indeterminate stage to Chagas cardiomyopathy;Echocardiography;2020-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3